有蹄类动物相关的专利数据

序号	专利名	申请号	申请日	公开（公告）号	公开（公告）日	发明人
181	牛促濾泡激素之表現及生物活性 EXPRESSION AND BIOACTIVITY OF BOVINE FOLLICLE STIMULATING HORMONE	TW097104980	2008-02-12	TW200846361A	2008-12-01	馬克A 高金 COLGIN, MARK A.; 理查G 當諾利 DONNELLY, RICHARD G.; 布萊德史塔德 STROUD, BRAD
本發明提供製備在哺乳動物(尤其是牛)具生物活性之重組bFSH之方法及使用重組bFSH以提高繁殖力之方法。本發明亦提供製備單鏈重組bFSH之方法。本發明重組bFSH可在牛及其他有蹄類動物中提高超數排卵、胚胎發育、及生殖效率。
182	Powder Composition for the Disinfection of Ungulates Baths	US14363666	2012-12-05	US20140287062A1	2014-09-25	Fabio Gelmi; Maurizio Venturini
A powder composition for the disinfection of ungulates' baths is disclosed. In particular the present invention relates to the use of a powder composition as a disinfecting agent for the preparation of the baths suitable for ungulates' prophylaxis. It comprises at least one chlorinated organic compound, copper sulphate, EDTA, a natural gum and an inorganic carbonate at specific weight percentages.
183	TRANSGENIC ANIMALS AND USES THEREOF	PCT/US2005/013618	2005-04-21	WO2005104835A2	2005-11-10	ROBL, James; KUROIWA, Yoshimi; KASINATHAN, Poothappillai; ISHIDA, Isao; TOMIZUKA, Kazuma
In general, the invention features genetically modified non-human mammals (e.g., bovines and other ungulates), and method of making these mammals. In particular, the invention features transgenic ungulates having reduced levels of endogenous IgM heavy chain and/or prion protein.
184	COMPOSITIONS AND METHODS FOR TREATMENT OF DISEASES	EP15813581.4	2015-10-14	EP3207054A2	2017-08-23	Prendergast, Patrick T.
A method for treating or preventing laminitis is provided comprising administering to an ungulate a therapeutically or prophylactically effective amount of a camelid protease inhibitor. Typically the ungulate is a horse and the camelid protease inhibitor is an inhibitor of equine metalloproteinases and equine serine proteases. The inhibitor may be isolated from blood from healthy camelid or may be generated by inoculating camelid with purified equine metalloproteinase enzymes and serine proteases or with snake venom metalloproteinases, such as those obtained from Bothrops jararaca. The inhibitor may a homodimer antibody or an antigen binding fragment of same. Also provided are compositions comprising such camelid protease inhibitors.
185	機能的α1,3ガラクトシルトランスフェラーゼを欠く動物に由来する組織生成物	JP2016048606	2016-03-11	JP2016105861A	2016-06-16	デイビッドアヤレス; ポールローリクト
【課題】機能的α1,3ガラクトシルトランスフェラーゼを欠く動物に由来する組織生成物の提供。【解決手段】本発明は、機能的α1,3ガラクトシルトランスフェラーゼ(α−1,3.GT)のいずれの発現も欠く、動物に由来する組織を提供する。そのような組織は、整形外科再構築および修復、皮膚修復および内部組織修復のような異種移植の分野において、または医療機器として用いることができる。上記動物はウシ、ブタまたはヒツジのような反芻動物または有蹄動物であり得る。α−1,3−GT遺伝子のいずれの機能的発現も欠く動物からの組織は、ブタ、ウシまたはヒツジのような出生前、新生、または未成熟または十分に成熟した動物から得ることができる。【選択図】なし
186	POWDER COMPOSITION FOR THE DISINFECTION OF UNGULATES' BATHS	PCT/EP2012/074464	2012-12-05	WO2013083612A1	2013-06-13	GELMI, Fabio; VENTURINI, Maurizio
A powder composition for the disinfection of ungulates' baths is disclosed. In particular the present invention relates to the use of a powder composition as a disinfecting agent for the preparation of the baths suitable for ungulates' prophylaxis. It comprises at least one chlorinated organic compound, copper sulphate, EDTA, a natural gum and an inorganic carbonate at specific weight percentages.
187	免疫組合物及方法 COMPOSITION AND METHOD FOR IMMUNIZATION	TW097120955	2008-06-05	TW200918552A	2009-05-01	格蘭湯瑪斯瑞林 RAWLIN, GRANT THOMAS; 洛伊邁可羅冰斯布朗 ROBINS-BROWNE, ROY MICHAEL; 希爾羅森布格 ROSENBERG, ZEIL
本發明係有關一種包含多株抗體且用於個體被動免疫對抗EV71之口服製劑組合物;及一種於超免疫有蹄類動物之初乳或者超免疫禽類蛋中產生對抗EV71抗原之多株抗體之方法。
188	ACAPSULAR P. MULTOCIDA HYAE DELETION MUTANTS	PCT/US2004021274	2004-07-02	WO2005003330A3	2005-03-03	BRIGGS ROBERT E; TATUM FRED M
A capsular hyaE deletion mutants of P. multocida can be administered to mammals, particularly ungulates, or birds to provide protective immunity against wild-type P. multocida, e.g., to prevent or reduce the severity of hemorrhagic septicemia or pneumonia in mammals, particularly livestock, ungulates, and companion animals, or fowl cholera in birds, particularly poultry.
189	Production of ungulates, preferably bovines that produce human immunoglobulins	US12151181	2008-05-05	US07820878B2	2010-10-26	Richard A. Goldsby; James M. Robl; Barbara A. Osborne; Yoshimi Kuroiwa
The present invention relates to a method of producing an ungulate having both copies of the IgM heavy chain (mu) rag-1 and/or rag-2 gene eliminated from its genome. Animals which have IgM, rag-1 and/or rag-2 eliminated from their genome are unable to conduct the gene rearrangements that are necessary to generate the antigen receptors of B- or T-lymphocytes, and therefore will not develop native B- or T-cells. Because they are unable to produce B- and T-lymphocytes, these IgM, rag-1, or rag-2 ungulates cannot reject human hematopoietic stem cell preparations, and B- and T-lymphocytes which develop therefrom. Therefore, the present invention also involves injecting into IgM, rag-1, and/or rag-2 deficient ungulates, in utero or shortly after birth, human B- and T-lymphocytes whose immune systems produce human immunoglobulin that can be processed for therapeutic uses in humans.
190	Production of ungulates, preferably bovines that produce human immunoglobulins	US12151181	2008-05-05	US20090276866A1	2009-11-05	Richard A. Goldsby; James M. Robl; Barbara A. Osborne; Yoshimi Kuroiwa
The present invention relates to a method of producing an ungulate having both copies of the IgM heavy chain (mu) rag-1 and/or rag-2 gene eliminated from its genome. Animals which have IgM, rag-1 and/or rag-2 eliminated from their genome are unable to conduct the gene rearrangements that are necessary to generate the antigen receptors of B- or T-lymphocytes, and therefore will not develop native B- or T-cells. Because they are unable to produce B- and T-lymphocytes, these IgM, rag-1, or rag-2 ungulates cannot reject human hematopoietic stem cell preparations, and B- and T-lymphocytes which develop therefrom. Therefore, the present invention also involves injecting into IgM, rag-1, and/or rag-2 deficient ungulates, in utero or shortly after birth, human B- and T-lymphocytes whose immune systems produce human immunoglobulin that can be processed for therapeutic uses in humans.
191	ACAPSULAR P. MULTOCIDA HYAE DELETION MUTANTS	PCT/US2004/021274	2004-07-02	WO2005003330A2	2005-01-13	BRIGGS, Robert, E.; TATUM, Fred, M.
A capsular hyaE deletion mutants of P. multocida can be administered to mammals, particularly ungulates, or birds to provide protective immunity against wild-type P. multocida, e.g., to prevent or reduce the severity of hemorrhagic septicemia or pneumonia in mammals, particularly livestock, ungulates, and companion animals, or fowl cholera in birds, particularly poultry.
192	Leg sock for horses	US12317655	2008-12-24	US20100154366A1	2010-06-24	Raymond Petterson
The present invention comprises a sock for use on the leg of a horse or ungulate, such as a cow, donkey or other hoofed animal. In the preferred embodiment the sock is tubular in shape having an upper opening and a lower opening. The sock is generally comprised of an upper cuff, main body and lower cuff. The upper cuff is configured to frictionally engage the leg of the horse such that the sock will not easily slip down on the leg of the horse. The main body is hollow and is configured to bunch together to hold the horse's body heat close to the leg of the horse. The lower cuff is configured to expand over said hoof of said ungulate and when over the hoof conform to or hug the small pastern.
193	ANIMAL REPELLING DEICER	PCT/US2011/056698	2011-10-18	WO2013058738A1	2013-04-25	ROSENBURGH, Neil Alexander; DAUM, Michelle Lee; BAGLEY, Jason Louis; PANNELL, Dan; SHELITE, Kristopher
Deicing products designed to deter ungulates are provided, along with methods of using those products to treat iced surfaces. The deicing product comprises a mixture of a deicer along with an ungulate repellent. The repellent can repel based on conditioned avoidance, fear, chemical irritation, and/or bad taste. The deicer can be a salt or a deicer solution. The invention is useful for deterring any ungulate that might be attracted to a component of the deicing product (e.g., the salt), but it is particularly useful for deterring deer.
194	Diagnostic, therapeutic and a vaccine against treponemes	US13433258	2012-03-28	US09364526B2	2016-06-14	Hank (Henry) Michael Lefler
The development of a diagnostic, therapeutic and making and administering a vaccine against ungulate diseases which involves spirochete bacteria in particular, Treponemes.
195	Diagnostic, Therapeutic And A Vaccine Against Treponemes	US13433258	2012-03-28	US20120251578A1	2012-10-04	Hank (Henry) Michael Lefler
The development of a diagnostic, therapeutic and making and administering a vaccine against ungulate diseases which involves spirochete bacteria in particular, Treponemes.
196	Horse shoe cassette system	US54278	1998-04-02	US5983611A	1999-11-16	Ingvar Alrik Smahl; Ronnie Smahl
A horse shoe cassette system for an animal's hoof. The cassette system comprises a plurality of hollow holders that are screwed into the hoof. Each holder has a threaded outside surface and a threaded inside opening defined therein. A flexible covering, of a general hollow ungulate shape to fit an ungulate's hoof, has a bottom plate that includes a first opening defined therein. A horse shoe is attached to the bottom plate of the flexible covering and the horse shoe has a second opening. A threaded screw member extends through the first and second openings and is screwed into the threaded inside opening of the holder disposed in the hoof.
197	조류 기피 조성물을 개선하기 위한 시각적 신호제의 용도	KR1020177005189	2015-07-01	KR1020170047243A	2017-05-04	볼린저케네스이주니어; 베르너스콧존
본발명은폴리시클릭퀴논, 구체적으로 9,10 안트라퀴논의기피효과를시너지적으로개선하기위한, 조류및 유제류에대한기능적먹이신호제(feeding cue)로서 UV 범위의광을흡수하는다양한안료및 색소의이용에관한것이다.
198	METHODS AND SYSTEMS FOR TREATING A HOOF ON AN UNGULATE MAMMAL	US13355259	2012-01-20	US20120203144A1	2012-08-09	Barbara Anne Collins
Methods and systems of treating a hoof on an ungulate mammal involve delivering reduced pressure to an interior portion of a hoof to promote profusion. In one instance, a method includes forming one or more apertures in a hoof wall of the hoof proximate to laminae that is proximate to a phalanx (P3) of the hoof, disposing a distribution manifold proximate to the one or more apertures, covering the distribution manifold and a portion of the ungulate mammal's exterior tissue with a sealing member to form a sealed space in which the distribution manifold is disposed, and providing reduced pressure to the distribution manifold in the sealed space. Other methods and systems are also presented.
199	COMPOSITIONS AND METHODS FOR TREATING HOOF DISEASES	EP09760439.1	2009-11-25	EP2349231B1	2017-08-23	DEMARCO, John P.; DEMARCO, Robert J.

200	COMPOSITIONS AND METHODS FOR TREATING HOOF DISEASES	EP09760439.1	2009-11-25	EP2349231A1	2011-08-03	DEMARCO, John P.; DEMARCO, Robert J.
The present invention is generally directed to compositions and methods for the treatment of an infectious disease of the foot of an animal. One aspect of the invention is directed to a method for preventing and/or treating one or more infectious diseases of the hoof in animals, comprising: preparing a copper-free and zinc-free composition comprising at least one cross- linking agent, wherein the cross-linking agent is not formaldehyde; and administering the composition to a lower leg and hoof area of said animal to prevent and/or treat said one or more infectious diseases. Another aspect of the invention is directed to a copper-free and zinc-free composition for the treatment and/or prevention of one or more infectious diseases of the hoof in animals, comprising at least one cross-linking agent, wherein said cross-linking agent is not formaldehyde. The present invention is also directed to a method for treating and / or preventing papillomatous digital dermatitis in an ungulate, comprising: preparing a copper-free and zinc- free composition comprising at least one cross-linking agent and at least one quaternary ammonium compound; and spraying or applying in a foam a therapeutically effective amount of said composition to a lower leg and hoof area of said ungulate in order to treat and / or prevent said papillomatous digitial dermatitis.

5 6 7 8 9 10 11 12 13 14

IPRDB

热门服务

关于我们

友情链接

联系方式